The Bethesda System for Reporting Thyroid Cytopathology: A Retrospective Review of its Diagnostic Utility at Johns Hopkins Aramco Healthcare, Saudi Arabia
| Autor: | Mohammed Gamal Aly, Abdulaziz Alabidi, Muataz H. Alhashem |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Risk Thyroid nodules medicine.medical_specialty Cytodiagnosis Biopsy Fine-Needle Population Saudi Arabia Malignancy Risk Assessment 03 medical and health sciences 0302 clinical medicine Atypia Humans Medicine Thyroid Neoplasms Thyroid Nodule 030223 otorhinolaryngology education Retrospective Studies education.field_of_study Suspicious for Malignancy medicine.diagnostic_test business.industry General surgery Reproducibility of Results Retrospective cohort study Patient Acceptance of Health Care medicine.disease Bethesda system for reporting thyroid cytopathology Fine-needle aspiration Otorhinolaryngology 030220 oncology & carcinogenesis Female Health Facilities business |
| Zdroj: | American Journal of Otolaryngology. 42:103088 |
| ISSN: | 0196-0709 |
| DOI: | 10.1016/j.amjoto.2021.103088 |
| Popis: | Purpose Fine needle aspiration (FNA) is the gold standard for assessment of thyroid nodules, with the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) used to predict the malignancy risk of these nodules. Our aim was to evaluate the diagnostic utility of the TBSRTC for a Saudi population, by comparing the malignancy risk based on histopathology to FNA-based diagnosis of each of the TBSRTC categories and to previously published malignancy risk in other population. Materials and methods This was a retrospective study of the data of 241 patients who underwent FNA assessment of thyroid nodules and surgical resection with histopathology at John Hopkins Aramco Healthcare, Dhahran, Saudi Arabia, between January 2016 and December 2019. Results The malignancy risk for each of the TBSRTC categories was as follows: non-diagnostic, 25%, benign; 5.74%; atypia of undetermined significance, 37%; suspicious for follicular neoplasm, 38%; suspicious for malignancy, 100%; and malignant, 95%. Our finding were comparable to previously published malignancy risks, except for a higher rate of malignancy in the benign category at 18% compared to 0–3%. Conclusion Our findings validate the diagnostic reproducibility of the TBSRTC for a Saudi population, with the risk of malignancy confirmed by histopathological assessment being consistent with those previously reported for other populations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect